Role of Board‐Certified Psychiatric Pharmacists in child and adolescent psychiatry

Stutzman, Danielle L.; Leiby, Lauren E.; Temelie, Andreea; Maroney, Megan; Williams, Andrew M.; Parmentier, Brittany L.; Payne, Gregory H.

doi:10.1002/jac5.1880

Cited by 1 publication

(2 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Inpatient psychiatric pharmacists should also help bridge transitions of care for all patients, especially those discharged after hospitalization for catatonia. 12 Patient and family education are particularly important and should include action steps in the case of missed lorazepam doses, such as returning to the emergency department if 2 or more consecutive doses are missed or refused by the patient. This discussion must also be transparent about the risk of lorazepam withdrawal symptoms, including seizures.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Pharmacologic management of adolescent catatonia: A dual-case series

Leiby,

Shiplett,

Lin

et al. 2024

Mental Health Clinician

View full text Add to dashboard Cite

Introduction Catatonia is a syndrome characterized by psychomotor and behavioral disturbances and is associated with a substantially increased mortality risk in adolescent patients. There is a dearth of published literature describing treatment strategies for pediatric patients with catatonia. This dual-case series will describe the treatment course of 2 adolescent patients with catatonia at our pediatric inpatient psychiatric facility. Case Series This case series presents 2 adolescent patients (a 17-year-old male and a 16-year-old female) who initially presented with worsening agitation and paranoia, later developing catatonia. Both patients required long durations of hospitalization and were treated with high-dose lorazepam before requiring the addition of electroconvulsive therapy (ECT). Discussion Treatment of pediatric patients with catatonia creates a significant burden on patients, families, and the healthcare system. Treatment with high-dose benzodiazepines is high risk, while ECT is both difficult to access and comes with its own risks. Both patients discussed are transitional age, meaning they will soon be young adults who will continue to require high-level psychiatric care. Psychiatric pharmacists have a large role to play in ensuring safe medication management for these complex patients. Conclusions This case series of 2 adolescent patients with catatonia demonstrates marginal reduction in symptoms with high-dose lorazepam in conjunction with ECT, with minimal side effects. This case series adds to the limited available literature regarding treatment of catatonia in pediatric patients and highlights the need for further study into effective treatment alternatives.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Access to psychiatric care continues to be a challenge for patients, especially children and adolescents. 12 Strain on patients, families, and the healthcare system is significant in these cases as they may require lengthy hospital stays. The financial and social burden of this care is significant.…”

Section: Discussionmentioning

confidence: 99%